fbpx

Year

2018
Lund, Sweden, 18:00 CET 1 February 2018 – BONESUPPORT HOLDING AB’s subsidiary BONESUPPORT AB has repaid the remaining debt under the loan facility from Kreos Capital V (UK) Ltd. The original loan agreement, which was signed in September 2016 included two tranches, one of EUR 13.4 million and one of EUR 8.9 million. BONESUPPORT has...
The neurotransmitter dopamine motivates us to act – sometimes sensibly but sometimes decidedly unwisely. In the run-up to the announcement of the winners of the 2018 Brain Prize on 6 March, one of last year’s winners – Professor Wolfram Schultz – tells us about his ground-breaking research into the brain’s reward system, dopamine and addiction....
Lund, Sweden, 18:00 CET 31 January 2018 – During January, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased due to the exercise of warrants. As of 31 January 2018, the number of shares and votes in BONESUPPORT HOLDING AB (publ) amounts to 50,368,766. About BONESUPPORT™ BONESUPPORT is an innovative and...
Lund, Sweden 08.30 CET, 23 January 2018 – BONESUPPORT (Nasdaq Stockholm: BONEX), an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform, announces that the Board of Directors has appointed Emil Billbäck as the new CEO of...
Lund, Sweden, 08.00 CET, 22 January 2018 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique platform  announces that a paper “Gelatin- hydroxyapatite-calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic...
SAN DIEGO – January 8, 2018 – Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, with a near-term focus on deadly fungal pathogens, today announced that Alan Fuhrman has been appointed as Chief Financial Officer of Amplyx. The Company also announced today that Ciara Kennedy, Ph.D., Chief Executive Officer of Amplyx, will present...
Palma, Spain, and San Diego, USA, January 8, 2018 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the appointment of Cris Calsada as Chief Financial Officer. Ms. Calsada joins Sanifit with over 20 years of corporate finance and executive experience in the life sciences and technology industries....
PARIS and CAMBRIDGE, Massachusetts, January 4, 2018 /PRNewswire/ — – Proceeds will be used to progress lead development programs – EB8018 for IBD and EO2315 for cancer – Secures €40 million loan facility ($48 million) from the European Investment Bank ENTEROME SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases (IBD) and immuno-oncology (IO) indications, announces that it...
If approved, BAREMSIS would be the first antiemetic with an indication for: –       rescue treatment of PONV after failed prophylaxis, and –       combination prophylaxis of PONV with standard antiemetics Cambridge, UK and Indianapolis, US – 4th January 2018: Acacia Pharma Group Ltd (“Acacia Pharma”), a pharmaceutical company developing and commercialising hospital products for US and...
A large international team of scientists has retrieved the entire DNA from an 11,500-year-old skeleton of a child from Alaska. Their finding has just been published in Nature. This discovery pushes the date of the first migration to the American continent back by 10,000 years. It also shows that, at one point, the Native Americans...
1 13 14 15

News

BONESUPPORT HOLDING AB (publ) announces that the patient enrolment schedule for the ongoing FORTIFY study is extended
21. August 2019
Parkinson-symptomer invaderede fra tarmsystemet
Parkinson’s symptoms invade from the gut
18. July 2019
Muslinge-lim som erstatning for operationstråd
Mussel glue to replace surgical sutures
17. July 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge